Endpoints News ١٧ فبراير ٢٠٢٦ Boehringer Ingelheim stops work on inhaled cystic fibrosis gene therapy
Endpoints News ١٤ فبراير ٢٠٢٦ Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
Endpoints News ١٣ فبراير ٢٠٢٦ Lilly appeals retatrutide classification ruling in case that could impact compounders
Endpoints News ١٣ فبراير ٢٠٢٦ Lundbeck migraine prevention drug succeeds in Phase 2, advancing new therapy class
Endpoints News ١٣ فبراير ٢٠٢٦ Immunic's private placement; Vertex's cystic fibrosis data in young kids
Endpoints News ١٣ فبراير ٢٠٢٦ Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEO
Endpoints News ١٣ فبراير ٢٠٢٦ PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarna